Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-8-14
pubmed:abstractText
Head and neck squamous cell carcinomas (HNSCCs) are known for their aggressive growth and propensity to metastasize. The authors investigated the effect of a novel nutrient mixture (NM) containing ascorbic acid, lysine, proline, and green tea extract on human HNSCC cell line FaDu in vivo and in vitro. Athymic male nude mice (n = 12) were inoculated with 3 x 10(6) FaDu cells subcutaneously and randomly divided into 2 groups: group A was fed a regular diet and group B a regular diet supplemented with 0.5% NM. Four weeks later, the mice were sacrificed and their tumors were excised, weighted, and processed for histology. In vitro, FaDu cells were cultured in Dulbecco's modified Eagle's medium and exposed to NM at 0 to 1000 microg/mL in triplicate. Cell proliferation was assessed by MTT assay, matrix metalloproteinase (MMP) secretion by gelatinase zymography, invasion through Matrigel, apoptosis by live-green caspases, and cell morphology by hematoxylin-eosin staining. NM inhibited the growth of tumors by 55% (P = .0002) and exhibited dose-dependent toxicity on FaDu cells in vitro, with 53% (P = .0003) at 1000 microg/mL NM. Zymography revealed MMP-2 and phorbol 12-myristate 13-acetate-induced MMP-9 secretion. NM inhibited secretion of both MMPs in a dose-dependent manner, with virtual total inhibition at 1000 microg/mL. NM significantly inhibited FaDu invasion through Matrigel with total block at 1000 microg/mL. NM induced dose-dependent apoptosis. In conclusion, NM has therapeutic potential in the treatment of HNSCC by significantly suppressing tumor growth and significantly inhibiting MMP secretion and invasion of HNSCC cells in vitro.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1534-7354
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
168-76
pubmed:meshHeading
pubmed-meshheading:19679626-Administration, Oral, pubmed-meshheading:19679626-Amino Acids, pubmed-meshheading:19679626-Animals, pubmed-meshheading:19679626-Apoptosis, pubmed-meshheading:19679626-Ascorbic Acid, pubmed-meshheading:19679626-Camellia sinensis, pubmed-meshheading:19679626-Carcinoma, Squamous Cell, pubmed-meshheading:19679626-Cell Line, Tumor, pubmed-meshheading:19679626-Cell Survival, pubmed-meshheading:19679626-Complementary Therapies, pubmed-meshheading:19679626-Food, pubmed-meshheading:19679626-Head and Neck Neoplasms, pubmed-meshheading:19679626-Humans, pubmed-meshheading:19679626-Male, pubmed-meshheading:19679626-Matrix Metalloproteinase 2, pubmed-meshheading:19679626-Matrix Metalloproteinase 9, pubmed-meshheading:19679626-Mice, pubmed-meshheading:19679626-Mice, Nude, pubmed-meshheading:19679626-Neoplasm Invasiveness, pubmed-meshheading:19679626-Plant Extracts, pubmed-meshheading:19679626-Tetradecanoylphorbol Acetate, pubmed-meshheading:19679626-Xenograft Model Antitumor Assays
pubmed:year
2009
pubmed:articleTitle
Marked inhibition of growth and invasive parameters of head and neck squamous carcinoma FaDu by a nutrient mixture.
pubmed:affiliation
Dr Rath Research Institute, Oncology Division, Santa Clara, California 95050, USA.
pubmed:publicationType
Journal Article